#fda approves optune in combination

Collection of fda approves optune in combination news, found 1 news.

FDA Approves Optune in Combination with Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

- Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune in ...